CCR2 and Hepatic fibrosis: Furthermore, circulating miR-19b-3p has been reported to be involved in liver fibrosis via inhibition of C–C motif chemokine receptor (CCR2), indicating that up-regulation of circulating miR-19b-3p suppresses liver fibrogenesis via the regulation of inflammation [49].